CEO of Palantir Technologies Alex Karp attends the Pennsylvania Energy and Innovation Summit on the campus of Carnegie Mellon University in Pittsburgh, Pennsylvania on July 15, 2025. Andrew Caballero-reynolds | Afp | Getty ImagesPalantir’s stock slumped more than 9% on Tuesday, falling for a fifth straight day to continue its pullback from all-time highs.The artificial intelligence software provider’s stock has slid more than 15% over the last five trading sessions, after a stellar earnings report earlier this month propelled shares to all-time highs. The report was Palantir’s first-ever $1 billion revenue quarter.Tuesday’s dip coincided with a broader market pullback.Palantir is…
Author: usaeverydaylife
new video loaded: How Zelensky Made Progress With TrumpBy Michael Schwirtz, Claire Hogan and Nikolay Nikolov•August 19, 2025President Volodymyr Zelensky of Ukraine had a remarkably different White House visit on Monday than the ambush he walked into six months ago. Michael Schwirtz, the global intelligence correspondent for The New York Times, explains how President Zelensky courted President Trump and managed to put the ball back in Vladimir V. Putin’s court.Recent episodes in InternationalInternational video coverage from The New York Times.International video coverage from The New York Times.Show more videos from International Source link
The Coinbase logo is displayed on a mobile phone screen with stock market percentages in the background.Idrees Abbas | Sopa Images | Lightrocket | Getty ImagesCrypto stocks suffered on Tuesday as investors fled tech stocks and riskier corners of the market.Among crypto exchanges, Coinbase and eToro fell more than 5% each, while Robinhood and Bullish both dropped more than 6%. Crypto financial services firm Galaxy Digital dropped 11%. In the burgeoning sector of crypto treasury firms, Strategy lost 7%, SharpLink Gaming slid 8%, Bitmine Immersion slumped 12% and DeFi Development tumbled 15%. Stablecoin issuer Circle lost 5%.Meanwhile, the price of…
After seven years of trying to break through resistance, Bloom Energy (BE) has finally done it. Bloom Energy is known as a “picks-and-shovels” infrastructure play for the booming artificial intelligence build-out. Prior to the AI-boom, BE was focused on being a clean distributed power provider for businesses that needed reliability and lower emissions. Now, BE provides on-site power generation boxes (sometimes called Bloom Boxes) that supply always-on electricity with lower carbon emissions than the grid, that can also run on hydrogen with zero emissions, to hospitals, factories, utilities, and — you guessed it — also to data centers. In fact, Bloom just…
U.S. President Donald Trump walks with North American Flat-Rolled Segment Senior Vice President and Chief Manufacturing Officer Scott Buckiso, Plant manager of Irvin and Fairless Plant Donald German and Mon Valley Works United Steel Corporation Vice President Kurt Barshick, as he visits U.S. Steel Corporation–Irvin Works in West Mifflin, Pennsylvania, U.S., May 30, 2025.Leah Millis | ReutersThe Trump administration has quietly expanded its 50% steel and aluminum tariffs to include more than 400 additional product categories, vastly increasing the reach and impact of this arm of its trade agenda.The new tariffs, which took effect Monday, expand the scope of the…
Home Depot shares soared Tuesday as investors saw past quarterly disappointments and looked forward to a better back half of the year. Revenue in the firm’s fiscal 2025 second quarter rose 4.9% year over year to $45.28 billion, missing expectations of $45.36 billion, according to estimates compiled by LSEG. Adjusted earnings per share (EPS) in the three months ended Aug. 3, were flat at $4.68 and were short of the consensus of $4.71, LSEG data showed. HD YTD mountain Home Depot YTD Despite being the first time Home Depot missed on both metrics since May 2014, the stock reversed into…
Analysts on Wall Street say expectations for Target’s second-quarter results due to be released before the opening bell on Wednesday are so low that the stock should be able to gain. The retailer’s earnings this week come alongside peer Walmart and a host of other leading big box retailers, in what’s shaping up as a key reading into the health of U.S. consumer spending. But Target’s forthcoming results come as the company has struggled in 2025. The stock is down 22% so far this year, and sales have been slowing for some time. The Minneapolis-based chain has seen investors and…
A version of this article first appeared in the CNBC Property Play newsletter with Diana Olick. Property Play covers new and evolving opportunities for the real estate investor, from individuals to venture capitalists, private equity funds, family offices, institutional investors and large public companies. Sign up to receive future editions, straight to your inbox.Senior living has long been a somewhat under-the-radar real estate play, with a somewhat unappealing reputation. But it is on the edge of a boom — a baby boom to be exact. More than 4 million boomers will hit 80 in the next five years, and occupancy at both active adult and…
Photos of a gun and parts of military electronics that were found on Shenghua Wen’s phone.Courtesy: U.S. Department of JusticeA Chinese national was sentenced to eight years in prison for conspiring to illegally smuggle guns, ammunition, and sensitive U.S. tech to North Korea, the Department of Justice said Tuesday.Shenghua Wen, 42, pleaded guilty in June to one count each of conspiring to violate the International Emergency Economic Powers Act and acting as an illegal agent of a foreign government.Wen had admitted to concealing the contraband inside shipping containers that he falsely claimed were filled with consumer goods bound for China.Wen…
Key PointsPharma giants are navigating U.S. President Donald Trump’s demands to bring U.S. drug prices in line with other developed nations.Eli Lilly’s decision to hike Mounjaro prices in the U.K. could spark similar moves from other firms, analysts say.The U.S. consistently pays the most in the world for many prescription drugs.Eli Lilly ‘s move to raise the U.K. list price of its blockbuster diabetes drug Mounjaro marks the start of prices hikes across Europe, analysts say, as pharmaceutical firms respond to U.S. President Donald Trump’s drug pricing demands. Lilly said Thursday that it had reached an agreement with the U.K. government to…
